Hersh Elliot V, Giannakopoulos Helen
Department of Oral Surgery and Pharmacology, University of Pennsylvania School of Dental Medicine, Philadelphia, PA 19104-6030, USA.
Dent Clin North Am. 2010 Oct;54(4):687-96. doi: 10.1016/j.cden.2010.06.009.
A clinically significant interaction between epinephrine or levonordefrin with nonselective beta-adrenergic blocking agents, although apparently rare in the dental setting, is potentially serious and can lead to significant hypertension with a concomitant reflex bradycardia. Based on the results of epinephrine infusion studies, the severity of the interaction seems dose related; small epinephrine doses cause less of a pressor response than larger doses. The interaction can be seen after intraoral submucosal injections but is generally of a smaller magnitude, at least with only 1 or 2 cartridges of lidocaine plus 1:100,000 epinephrine. However as demonstrated by 1 case report, some individuals are hypersensitive to this interaction. Inadvertent intravascular injections of local anesthetic plus vasoconstrictor and the use of high doses of vasoconstrictor are likely to result in a more pronounced response. Patients with significant cardiovascular disease may be especially vulnerable to the most serious sequelae resulting from the pressor reactions of the drug combination.
肾上腺素或去甲左啡诺与非选择性β-肾上腺素能阻滞剂之间存在临床上显著的相互作用,尽管在牙科环境中显然很少见,但这种相互作用潜在严重,可导致显著的高血压并伴有反射性心动过缓。根据肾上腺素输注研究的结果,这种相互作用的严重程度似乎与剂量有关;小剂量肾上腺素引起的升压反应比大剂量小。这种相互作用在口腔黏膜下注射后可见,但一般程度较小,至少使用1或2支含1:100,000肾上腺素的利多卡因时是这样。然而,正如1例病例报告所示,一些个体对这种相互作用过敏。意外血管内注射局部麻醉剂加血管收缩剂以及使用高剂量血管收缩剂可能会导致更明显的反应。患有严重心血管疾病的患者可能特别容易受到药物组合升压反应导致的最严重后遗症的影响。